Cresco Labs Inc. SEC filings CRLBF

Cresco Labs Inc. has 93 filings in SEC EDGAR's recent list, going back to Jan 13, 2021. Its latest annual report, Form 40-F, was filed on Mar 6, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.

Cresco Labs Inc. SEC filings
Form Description Filed Period
40-F Annual report (Canadian issuer) Mar 6, 2026 Dec 31, 2025
40-F Annual report (Canadian issuer) Mar 14, 2025 Dec 31, 2024
40-F Annual report (Canadian issuer) Mar 18, 2024 Dec 31, 2023
40-F Annual report (Canadian issuer) Mar 22, 2023 Dec 31, 2022
40-F Annual report (Canadian issuer) Apr 5, 2022 Dec 31, 2021
40-F/A Amended annual report (Canadian issuer) Apr 29, 2021 Dec 31, 2020
40-F Annual report (Canadian issuer) Mar 30, 2021 Dec 31, 2020

Showing 7 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
CRLBF (OTC)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Chicago, IL
SEC filer status
, Emerging growth company
SEC CIK
1832928

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.